These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33591382)

  • 21. Chromosomal Microarray Analysis Compared With Noninvasive Prenatal Testing in Pregnancies With Abnormal Maternal Serum Screening.
    Sagi-Dain L; Salzer Sheelo L; Brabbing-Goldstein D; Matar R; Kahana S; Agmon-Fishman I; Klein C; Gurevitch M; Basel-Salmon L; Maya I
    Obstet Gynecol; 2022 May; 139(5):877-887. PubMed ID: 35576346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal Microarray Analysis for the Fetuses with Aortic Arch Abnormalities and Normal Karyotype.
    Wu X; Li Y; Su L; Xie X; Cai M; Lin N; Huang H; Lin Y; Xu L
    Mol Diagn Ther; 2020 Oct; 24(5):611-619. PubMed ID: 32651932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal Diagnosis of Talipes Equinovarus by Ultrasound and Chromosomal Microarray Analysis: A Chinese Single-Center Retrospective Study.
    Huang R; Yang X; Zhou H; Fu F; Cheng K; Wang Y; Ma C; Li R; Jing X; Han J; Zhen L; Pan M; Li D; Liao C
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of chromosomal microarray in anomalous fetuses.
    Parchem JG; Sparks TN; Gosnell K; Norton ME
    Prenat Diagn; 2018 Jan; 38(2):140-147. PubMed ID: 29297200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities.
    Fiorentino F; Napoletano S; Caiazzo F; Sessa M; Bono S; Spizzichino L; Gordon A; Nuccitelli A; Rizzo G; Baldi M
    Eur J Hum Genet; 2013 Jul; 21(7):725-30. PubMed ID: 23211699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A two-year prospective study assessing the performance of fetal chromosomal microarray analysis and next-generation sequencing in high-risk pregnancies.
    Ridnõi K; Muru K; Keernik M; Pajusalu S; Ustav EL; Tammur P; Mölter-Väär T; Kahre T; Šamarina U; Asser K; Szirko F; Reimand T; Õunap K
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1787. PubMed ID: 34486251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of chromosomal microarray analysis among fetuses with normal karyotype and single system anomaly or nonspecific sonographic findings.
    Hui AS; Chau MHK; Chan YM; Cao Y; Kwan AH; Zhu X; Kwok YK; Chen Z; Lao TT; Choy KW; Leung TY
    Acta Obstet Gynecol Scand; 2021 Feb; 100(2):235-243. PubMed ID: 32981064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The yield of chromosomal microarray analysis among pregnancies terminated due to fetal malformations.
    Pasternak Y; Daykan Y; Tenne T; Reinstein E; Miller N; Shechter-Maor G; Maya I; Biron-Shental T; Sukenik Halevy R
    J Matern Fetal Neonatal Med; 2022 Jan; 35(2):336-340. PubMed ID: 31973614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of noninvasive prenatal screening-detectable findings.
    Maya I; Salzer Sheelo L; Brabbing-Goldstein D; Matar R; Kahana S; Agmon-Fishman I; Klein C; Gurevitch M; Basel-Salmon L; Sagi-Dain L
    Am J Obstet Gynecol; 2022 Apr; 226(4):562.e1-562.e8. PubMed ID: 34762861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-visualization of fetal gallbladder in microarray era - a retrospective cohort study and review of the literature.
    Sagi-Dain L; Singer A; Hadid Y; Sharony R; Vinkler C; Bar-Shira A; Segel R; Ben Shachar S; Maya I
    J Matern Fetal Neonatal Med; 2019 Aug; 32(16):2643-2648. PubMed ID: 29455582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal diagnosis of Miller-Dieker syndrome by chromosomal microarray.
    Shi X; Huang W; Lu J; He W; Liu Q; Wu J
    Ann Hum Genet; 2021 Mar; 85(2):92-96. PubMed ID: 33026665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical value of screening prenatal ultrasound combined with chromosomal microarrays in prenatal diagnosis of chromosomal abnormalities.
    Jiang H; Kong X; Bian W; Liu J; Xu Y; Cui A; Cao X
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2324348. PubMed ID: 38466173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical value of genome-wide chromosome microarray technique in diagnosis of fetal cerebral ventriculomegaly].
    Peng YX; Qiu YW; Chang QX; Yu YH; Zhong M; Li KR
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):353-357. PubMed ID: 29643044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical use of chromosomal microarray analysis in detection of fetal chromosomal rearrangements: a study from China Mainland.
    Wu Y; Wang Y; Tao J; Han X; Zhao X; Liu C; Gao L; Cheng W
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():44-50. PubMed ID: 28340467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The yield of chromosomal microarray in pregnancies with congenital cardiac defects and normal noninvasive prenatal screening.
    Sagi-Dain L; Singer A; Segel R; Berger R; Kanengisser-Pines B; Maya I
    Am J Obstet Gynecol; 2021 Sep; 225(3):333.e1-333.e14. PubMed ID: 34052193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefit versus risk of chromosomal microarray analysis performed in pregnancies with normal and positive prenatal screening results: A retrospective study.
    Moshonov R; Hod K; Azaria B; Abadi-Korek I; Berger R; Shohat M
    PLoS One; 2021; 16(4):e0250734. PubMed ID: 33901244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal and postnatal findings in small-for-gestational-age fetuses without structural ultrasound anomalies at 18-24 weeks.
    de Wit MC; Srebniak MI; Joosten M; Govaerts LC; Kornelisse RF; Papatsonis DN; de Graaff K; Knapen MF; Bruggenwirth HT; de Vries FA; Van Veen S; Van Opstal D; Galjaard RJ; Go AT
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):342-348. PubMed ID: 27102944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal congenital gastrointestinal obstruction: prenatal diagnosis of chromosome microarray analysis and pregnancy outcomes.
    Ni M; Zhu X; Liu W; Gu L; Zhu Y; Cao P; Gu Y; Xu Y; Dai C; Wu X; Yang Y; Zhou C; Li J
    BMC Pregnancy Childbirth; 2023 Jul; 23(1):503. PubMed ID: 37422671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.
    Su L; Huang H; An G; Cai M; Wu X; Li Y; Xie X; Lin Y; Wang M; Xu L
    Mol Genet Genomic Med; 2019 Aug; 7(8):e811. PubMed ID: 31209990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Universal chromosomal microarray analysis reveals high proportion of copy-number variants in low-risk pregnancies.
    Stern S; Hacohen N; Meiner V; Yagel S; Zenvirt S; Shkedi-Rafid S; Macarov M; Valsky DV; Porat S; Yanai N; Frumkin A; Daum H
    Ultrasound Obstet Gynecol; 2021 May; 57(5):813-820. PubMed ID: 32202684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.